Timing of administration of antenatal magnesium sulphate and correlation with umbilical cord blood magnesium levels in preterm babies.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this observational study publication.

To assess the cord blood magnesium concentration in relation to the timing of MgSO4 and delivery.

To achieve ROC in relation to optimum level of cord blood magnesium concentration in relation to neonatal outcome variables.

Why It Was Studied

Understanding the determinants of the magnesium levels in cord blood aids in determining the appropriate timing and length of administration.

Who Took Part

The study group was 2 women.

PubMed indexes the participants as adults, women only.

How the Study Was Run

Cord blood was collected for magnesium level estimation.

Baby followed 24 h after delivery.

ROC analysis performed for predicting an optimal cut-off for a continuous predictor predicting binary outcome.

What Was Measured

Understanding the determinants of the magnesium levels in cord blood aids in determining the appropriate timing and length of administration.

PubMed files the paper under topics including Magnesium Sulfate, Fetal Blood, Magnesium, Infant, Premature, Premature Birth, Neuroprotective Agents and Gestational Age.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc in 2 women.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (European journal of obstetrics, gynecology, and reproductive biology), a journal based in Ireland.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.